Exagen Inc. provided revenue guidance for the third quarter of 2023. Revenue guidance for the third quarter of 2023 in the range of $10 million to $10.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.412 USD | +0.15% | +3.07% | -29.04% |
Apr. 26 | Exagen Inc. Announces Changes in Board of Directors | CI |
Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.04% | 24.34M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Provides Revenue Guidance for the Third Quarter of 2023